Wednesday, 26 August 2026European Markets

VERIMATRIX Stock Is 9% Down So Far Today

Loading stream...

(vianews) - shares of verimatrix (cac 40: vmx.pa) dropped 9.83% to €0.65 at 13:07 est on monday, following the last session's downward trend. cac 40 is falling 2.11% to €7,068.03, after four sequential sessions in a row of losses. this seems, up until now, an all-around negative trend trading session today.

about verimatrix

verimatrix société anonyme provides security solutions that protect digital content, applications, and devices worldwide. the company offers security solutions for various markets, including automotive, sports, financial services, healthcare, internet of things, live sports, media and entertainment, and tv, as well as for content owners. the company was formerly known as inside secure s.a. and changed its name to verimatrix société anonyme in july 2017. verimatrix société anonyme was founded in 1995 and is based in meyreuil, france.

earnings per share

as for profitability, verimatrix has a trailing twelve months eps of €-0.021.

volume

today's last reported volume for verimatrix is 210271 which is 147.76% above its average volume of 84868.

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, verimatrix's stock is considered to be overbought (>=80).

volatility

verimatrix's last week, last month's, and last quarter's current intraday variation average was a negative 2.67%, a negative 0.73%, and a positive 2.27%.

verimatrix's highest amplitude of average volatility was 4.11% (last week), 2.23% (last month), and 2.27% (last quarter).

more news about verimatrix (vmx.pa).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com